Cargando…
Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With Human Immunodeficiency Virus
BACKGROUND: International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1078, a randomized noninferiority study designed to compare the safety of starting isoniazid preventive therapy (IPT) in women living with human immunodeficiency virus (HIV) either during pregnancy or after deliv...
Autores principales: | Theron, Gerhard, Montepiedra, Grace, Aaron, Lisa, McCarthy, Katie, Chakhtoura, Nahida, Jean-Philippe, Patrick, Zimmer, Bonnie, Loftis, Amy James, Chipato, Tsungai, Nematadzira, Teacler, Nyati, Mandisa, Onyango-Makumbi, Carolyne, Masheto, Gaerolwe, Ngocho, James, Tongprasert, Fuanglada, Patil, Sandesh, Lespinasse, Dominique, Weinberg, Adriana, Gupta, Amita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315231/ https://www.ncbi.nlm.nih.gov/pubmed/32997744 http://dx.doi.org/10.1093/cid/ciaa1482 |
Ejemplares similares
-
Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial
por: Mandima, Patricia, et al.
Publicado: (2023) -
Pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping
por: Gausi, Kamunkhwala, et al.
Publicado: (2020) -
Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial
por: Cherkos, Ashenafi S., et al.
Publicado: (2023) -
Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women
por: Mathad, Jyoti S, et al.
Publicado: (2021) -
Antiretroviral Therapy Adherence During and Postbreastfeeding Cessation Measured by Tenofovir Levels in Hair
por: Nematadzira, Teacler G., et al.
Publicado: (2022)